BRUSSELS WARNS NOVARTIS AND JOHNSON & JOHNSON ABOUT ANTI-TRUST FINES
February 1st, 2013
PHARMACEUTICAL giants Novartis and Johnson & Johnson have been formally warned by the European Commission that they could be hit by massive anti-trust fines over an agreement struck by their Dutch subsidiaries on sales of pain-killer fentanyl.Brussels has said the agreement might have delayed the market entry of a cheaper generic medicine in the Netherlands, breaking European Union (EU) antitrust rules. It has sent a formal Statement of Objections to the companies, asking them to explain its concerns. If they fail, the Commission might impose anti-trust ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.